1. Home/
  2. Compounds/
  3. tanespimycin:bortezomib (250:1 mol/mol)

tanespimycin:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tanespimycin:bortezomib (250:1 mol/mol)
PharmacoGx tanespimycin:bortezomib (250:1 mol/mol)

Cell lines tested with tanespimycin:bortezomib (250:1 mol/mol)

797 cell lines have been tested with this compound, using data from 1 dataset(s).
BT145 N/A CTRPv21
BT179 N/A CTRPv21
BT112 N/A CTRPv21
BT164 N/A CTRPv21
BT224 N/A CTRPv21
HSTS N/A CTRPv21
KRIJ N/A CTRPv21
PSTS N/A CTRPv21
U-CH1 N/A CTRPv21
HS888LU N/A CTRPv21
Download CSV

Tissues tested with tanespimycin:bortezomib (250:1 mol/mol)

25 tissues have been tested with this compound, using data from 1 dataset(s).
central nervous systemCTRPv245
breastCTRPv237
stomachCTRPv232
urinary tractCTRPv222
thyroidCTRPv210
biliary tractCTRPv25
skinCTRPv244
haematopoietic and lymphoid tissueCTRPv2135
autonomic gangliaCTRPv211
liverCTRPv221
Download CSV
Download Data as CSV

Top molecular features associated with response to tanespimycin:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA NUP54 CTRPv2 AAC 0.2 6e-08
mRNA INTS7 CTRPv2 AAC 0.21 8e-08
mRNA LIN9 CTRPv2 AAC 0.2 1e-07
mRNA GTF3C6 CTRPv2 AAC 0.2 1e-07
mRNA GNPNAT1 CTRPv2 AAC 0.21 2e-07
mRNA LRP8 CTRPv2 AAC 0.19 4e-07
mRNA AC110615.1 CTRPv2 AAC 0.19 7e-07
mRNA PUS1 CTRPv2 AAC 0.18 1e-06
mRNA UCK2 CTRPv2 AAC 0.18 3e-06
mRNA WWC1 CTRPv2 AAC -0.21 4e-06
Download CSV